Evaluation of the Phased Radio Frequency Ablation System

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 199 participants.

Also called NCT01693120

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 199 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01693120
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Hungary, Netherlands, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01693120. Allocation not applicable; no masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2017-02-07 (actual). Results posted on 2018-03-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Phased Radio Frequency Ablation System
Acronym
VICTORY-AF
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Medtronic Phased RF Ablation System
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct01693120
Content hash
d284cc9ab2fd8abf8126f2402c1acdbc53b775cd36fc96396700b2cddca87b3b